Masimo Corporation is an American health technology and consumer electronics company based in Irvine, California. The company manufactures patient monitoring devices and technologies, including non-invasive sensors using optical technology, patient management, and telehealth platforms. In 2022, the company expanded into home audio by acquiring Sound United, and began to manufacture health-oriented wearable devices.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| MASI | MASIMO CORP | 2025-12-02 07:00:49 | 143.95 | -0.07 | -0.05 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MASI | 0000937556 | MASIMO CORP | US5747951003 | 549300Q4A8JK0PIYCU29 | 330368882 | Nasdaq | 3845 | Electromedical & Electrotherapeutic Apparatus | 0103 | DE | 52 DISCOVERY | IRVINE | CA | 92618 | UNITED STATES | US | 949-297-7000 | 52 DISCOVERY, IRVINE, CA, 92618 | 52 DISCOVERY, IRVINE, CA, 92618 | — | Medical technology | 1989 | Catherine Szyman | 3,600 | http://masimo.com | 3,400,000,000 | 53,100,000 | 53,713,949 | Masimo Corporation is an American health technology and consumer electronics company based in Irvine, California. The company manufactures patient monitoring devices and technologies, including non-invasive sensors using optical technology, patient management, and telehealth platforms. In 2022, the company expanded into home audio by acquiring Sound United, and began to manufacture health-oriented wearable devices. | 2025-11-27 15:37:38 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 3,400,000,000 | -3,100,000,000 | -47.6923 | 53,948,792 | 1,035,626 | 1.9572 |
| 2023 | 6,500,000,000 | 0 | 0 | 52,913,166 | 0 | 0 |
| 2022 | 6,500,000,000 | -4,400,000,000 | -40.367 | 52,913,166 | -2,451,524 | -4.428 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Bilal Muhsin | Chief Operating Officer | 2021 | 574,998 | 0 | 1,799,991 | 402,612 | 8,700 | 3,386,139 |
| Tao Levy | Executive Vice President | 2021 | 362,461 | 0 | 899,870 | 258,750 | 10,393 | 1,831,393 |
| Joe Kiani | Chief Executive Officer, Chairman Of The Board | 2021 | 1,176,664 | 0 | 8,999,953 | 1,647,794 | 1,395,450 | 16,219,278 |
| Micah Young | Chief Financial Officer, Executive Vice President | 2021 | 449,131 | 0 | 899,870 | 314,480 | 10,200 | 1,973,600 |
| Tom Mcclenahan | Corporate Secretary, Executive Vice President, General Counsel | 2021 | 447,133 | 0 | 899,870 | 313,081 | 14,314 | 1,974,317 |
| Fiscal Year | Employee Count |
|---|---|
| 2019 | 1,600 |
| 2018 | 1,500 |
| 2017 | 1,400 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 2,094,400,000 | 2,048,100,000 | 2,035,800,000 |
| Cost Of Revenue | 1,090,000,000 | 1,044,600,000 | 977,000,000 |
| Gross Profit | 1,004,400,000 | 1,003,500,000 | 1,058,800,000 |
| Research And Development Expenses | 222,800,000 | 175,200,000 | 191,400,000 |
| General And Administrative Expenses | 743,800,000 | 664,000,000 | 657,400,000 |
| Operating Expenses | 1,271,100,000 | 867,000,000 | 848,800,000 |
| Operating Income | -266,700,000 | 136,500,000 | 210,000,000 |
| Net Income | -304,900,000 | 81,500,000 | 143,500,000 |
| Earnings Per Share Basic | -5.72 | 1.54 | 2.68 |
| Earnings Per Share Diluted | -5.72 | 1.51 | 2.6 |
| Weighted Average Shares Outstanding Basic | 53,300,000 | 52,800,000 | 53,600,000 |
| Weighted Average Shares Outstanding Diluted | 53,300,000 | 54,100,000 | 55,200,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 177,600,000 | 163,000,000 | 202,900,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 11,400,000 | 355,500,000 | 445,900,000 |
| Inventories | 459,200,000 | 545,000,000 | 501,000,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 145,100,000 | 168,400,000 | 158,800,000 |
| Total Assets Current | 1,225,800,000 | 1,231,900,000 | 1,308,600,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 381,600,000 | 424,400,000 | 402,500,000 |
| Other Assets Non Current | 100,100,000 | 89,300,000 | 114,000,000 |
| Total Assets Non Current | 400,300,000 | 425,900,000 | 404,200,000 |
| Total Assets | 2,625,700,000 | 3,041,500,000 | 3,210,600,000 |
| Accounts Payable | 252,800,000 | 251,500,000 | 276,800,000 |
| Deferred Revenue | 95,500,000 | 87,300,000 | 80,600,000 |
| Short Term Debt | 37,300,000 | 34,300,000 | 15,100,000 |
| Other Liabilities Current | 185,800,000 | 162,400,000 | 183,300,000 |
| Total Liabilities Current | 617,700,000 | 563,800,000 | 630,000,000 |
| Long Term Debt | 765,200,000 | 906,000,000 | 956,700,000 |
| Other Liabilities Non Current | 128,100,000 | 129,500,000 | 136,500,000 |
| Total Liabilities Non Current | 956,100,000 | 1,112,900,000 | 1,241,700,000 |
| Total Liabilities | 1,573,800,000 | 1,676,700,000 | 1,871,700,000 |
| Common Stock | 100,000 | 100,000 | 100,000 |
| Retained Earnings | 1,490,900,000 | 1,795,800,000 | 1,714,300,000 |
| Accumulated Other Comprehensive Income | — | — | — |
| Total Shareholders Equity | 1,051,900,000 | 1,364,800,000 | 1,338,900,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 103,000,000 | 98,300,000 | 136,100,000 |
| Share Based Compensation Expense | 41,500,000 | 7,000,000 | 47,700,000 |
| Other Non Cash Income Expense | -98,700,000 | -800,000 | -500,000 |
| Change In Accounts Receivable | 65,000,000 | -90,200,000 | 138,500,000 |
| Change In Inventories | 7,500,000 | 69,200,000 | 155,900,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | — | — | — |
| Change In Accounts Payable | 14,800,000 | -19,600,000 | 60,500,000 |
| Change In Other Liabilities | -10,500,000 | 3,600,000 | 4,100,000 |
| Cash From Operating Activities | 196,400,000 | 94,100,000 | 29,400,000 |
| Purchases Of Marketable Securities | — | — | — |
| Sales Of Marketable Securities | — | — | 0 |
| Acquisition Of Property Plant And Equipment | 20,000,000 | 44,000,000 | 52,800,000 |
| Acquisition Of Business | 0 | -7,500,000 | 999,700,000 |
| Other Investing Activities | — | — | 1,700,000 |
| Cash From Investing Activities | -51,200,000 | -81,200,000 | -1,057,700,000 |
| Tax Withholding For Share Based Compensation | 11,800,000 | 12,900,000 | 25,400,000 |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | 0 | 0 | 401,500,000 |
| Issuance Of Long Term Debt | — | — | — |
| Repayment Of Long Term Debt | 237,800,000 | 240,200,000 | 135,400,000 |
| Other Financing Activities | — | — | — |
| Cash From Financing Activities | -125,600,000 | -57,100,000 | 520,400,000 |
| Change In Cash | 13,200,000 | -41,400,000 | -538,800,000 |
| Cash At End Of Period | 177,600,000 | 163,000,000 | 202,900,000 |
| Income Taxes Paid | 41,900,000 | 54,400,000 | 87,300,000 |
| Interest Paid | 39,100,000 | 51,000,000 | 23,000,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | -5.72 | 1.54 | 2.68 |
| Price To Earnings Ratio | -29.8899 | 76.1104 | 55.2052 |
| Earnings Growth Rate | -471.4286 | -42.5373 | -35.5769 |
| Price Earnings To Growth Ratio | 0.0634 | -1.7893 | -1.5517 |
| Book Value Per Share | 19.7355 | 25.8485 | 24.9795 |
| Price To Book Ratio | 8.6631 | 4.5345 | 5.9229 |
| Ebitda | -116,400,000 | 284,500,000 | 392,600,000 |
| Enterprise Value | 9,737,601,000 | 6,965,988,000 | 8,699,020,000 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 0.7629 | 0.689 | 0.7258 |
| Capital Expenditures | 60,200,000 | 120,200,000 | 265,807,000 |
| Free Cash Flow | 136,200,000 | -26,100,000 | -236,407,000 |
| Return On Equity | -0.2899 | 0.0597 | 0.1072 |
| One Year Beta | 0.6267 | 0.7503 | 1.2998 |
| Three Year Beta | 1.0803 | 1.1082 | 0.8088 |
| Five Year Beta | 0.7912 | 0.835 | 0.8597 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Ahmed Omar | CTIO & EVP of Engineering | 2025-11-13 | 2,474 | A | 4,242 |
| Ahmed Omar | CTIO & EVP of Engineering | 2025-11-13 | 974 | D | 3,268 |
| Ahmed Omar | CTIO & EVP of Engineering | 2025-11-13 | 2,474 | D | 0 |
| Tripodi Blair | COO, Consumer Division | 2025-09-23 | 15,000 | A | 21,896 |
| Tripodi Blair | COO, Consumer Division | 2025-09-23 | 8,078 | D | 13,818 |
| Name Of Reporting Person | Type Of Reporting Person | Report Date | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Thomas H Tuberville | Senator | 2022-11-10 | Sale (Full) | 2022-10-05 | Joint | $1,001 - $15,000 |
| Thomas H Tuberville | Senator | 2022-04-08 | Purchase | 2022-03-30 | Joint | $1,001 - $15,000 |
| Thomas R Tillis | Senator | 2015-02-26 | Sale (Full) | 2015-02-13 | Joint | $1,001 - $15,000 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Kevin Hern | 2025-10-16 | OK01 | Sale | 2025-09-26 | Joint | $15,001 - $50,000 |
| Kevin Hern | 2023-01-13 | OK01 | Sale | 2022-12-19 | Joint | $50,001 - $100,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| JPMORGAN CHASE & CO | 2025-09-30 | 15,926,694 | 107,941 | 147.55 |
| Liontrust Investment Partners LLP | 2025-09-30 | 100,613,607 | 681,895 | 147.55 |
| CIBC Private Wealth Group LLC | 2025-09-30 | 2,213 | 15 | 147.5333 |
| Bell Investment Advisors, Inc | 2025-09-30 | 4,279 | 29 | 147.5517 |
| Wilmington Savings Fund Society, FSB | 2025-09-30 | 1,313,048 | 8,899 | 147.5501 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| Voya VARIABLE PORTFOLIOS INC | 2025-09-30 | Class S | IRGUX | 1,137 | 167,764.35 | 0.2137 |
| Voya VARIABLE PORTFOLIOS INC | 2025-09-30 | Class I | IRGJX | 1,137 | 167,764.35 | 0.2137 |
| SEI INSTITUTIONAL MANAGED TRUST | 2025-09-30 | Class Y | STMPX | 3,863 | 569,985.65 | 0.0818 |
| SEI INSTITUTIONAL MANAGED TRUST | 2025-09-30 | CLASS F | STMSX | 3,863 | 569,985.65 | 0.0818 |
| SEI INSTITUTIONAL MANAGED TRUST | 2025-09-30 | Class Y | SLFYX | 273 | 40,281.15 | 0.0078 |